Similar articles

• Data from the French cohort studies and framing the French contraceptive guidelines.

  Heard I. Heard I. J Acquir Immune Defic Syndr. 2005 Mar;38 Suppl 1:S29-31. doi: 10.1097/01.qai.0000167037.56396.1a. J Acquir Immune Defic Syndr. 2005. PMID: 15867610 No abstract available.
• Population-based study evaluating association between selected antiretroviral therapies and potential oral contraceptive failure.

  Clark RA, Theall K. Clark RA, et al. J Acquir Immune Defic Syndr. 2004 Sep 1;37(1):1219-20. doi: 10.1097/01.qai.0000136724.15758.ae. J Acquir Immune Defic Syndr. 2004. PMID: 15319685 No abstract available.
• Data from the United States Food and Drug Administration.

  Zheng JH. Zheng JH. J Acquir Immune Defic Syndr. 2005 Mar;38 Suppl 1:S24-6. doi: 10.1097/01.qai.0000167035.48772.13. J Acquir Immune Defic Syndr. 2005. PMID: 15867608 No abstract available.
• [Oral contraceptives: 30 vs 20 micrograms of ethinyl estradiol (EE)].

  Urdinola J. Urdinola J. Adv Contracept. 1994 Jul;10 Suppl 1:41-9. Adv Contracept. 1994. PMID: 7839871 Review. Spanish. No abstract available.
• Interactions with hormonal contraception.

  Elliman A. Elliman A. Br J Fam Plann. 2000 Apr;26(2):109-11, quiz 111,122. doi: 10.1783/147118900101194193. Br J Fam Plann. 2000. PMID: 10896460 Review. No abstract available.